• Japanese
  • Korean
  • Chinese
Cover Image

Global Biopharmaceuticals Market 2011-2015

Abstract

TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biopharmaceuticals landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Pfizer Inc., Abbott Laboratories Inc., Sanofi S.A., AstraZeneca plc, and Johnson and Johnson Services Inc. Other vendors in the market are GlaxoSmithKline plc, Merck Sereno S.A., UCB S.A., and Boehringer Ingelheim GmbH.

Key questions answered in this report:

  • What will the market size be in 2015 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

  • Market Overview
  • Key Products

04. Market Landscape

  • Market Size
  • Market Segmentation
  • 04.1. Global Monoclonal Antibodies Market
  • 04.2. Global Growth Factors Market
  • 04.3. Global Insulin Market
  • 04.4. Global Growth Hormones Market
  • Five Forces Analysis

05. Geographical Segmentation

06. Key Leading Countries

  • USA
  • Japan
  • UK
  • Germany

07. Rate of Incidence and Prevalence

  • Cancer
  • Musculoskeletal Diseases
  • Diabetes
  • Influenza
  • Hepatitis C

08. Vendor Landscape

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

  • Drivers and their Impact: End-users
  • Drivers and their Impact: Geography
  • Key

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

  • 15.1. Pfizer Inc.
    • Business Overview
    • SWOT Analysis
  • 15.2. Abbott Laboratories Inc.
    • Business Overview
    • SWOT Analysis
  • 15.3. Sanofi S.A.
    • Business Overview
    • SWOT Analysis
  • 15.4. AstraZeneca plc
    • Business Overview
    • SWOT Analysis
  • 15.5. Johnson and Johnson Services Inc.
    • Business Overview
    • SWOT Analysis

16. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Biologic Segmentation of the Global Biopharmaceuticals Market
  • Exhibit 2: Global Biopharmaceuticals Market 2011-2015 (US$ billion)
  • Exhibit 3: Global Biopharmaceuticals Market Segmentation by Biologic Components 2011
  • Exhibit 4: Global Biopharmaceuticals Market 2011-2015 (percent)
  • Exhibit 5: Global Biopharmaceuticals Market 2011-2015 (in US$ billion)
  • Exhibit 6: Global Monoclonal Antibodies Market 2011-2015 (US$ billion)
  • Exhibit 7: Global Growth Factors Market 2011-2015 (US$ billion)
  • Exhibit 8: Biologic Segmentation of the Global Growth Factors Market
  • Exhibit 9: Global Growth Factors Market Segmentation by Biologic Components 2011
  • Exhibit 10: Global Growth Factors Market 2011-2015 (percent)
  • Exhibit 11: Global Growth Factors Market 2011-2015 (in US$ billion)
  • Exhibit 12: Global Insulin Market 2011-2015 (US$ billion)
  • Exhibit 13: Global Growth Hormones Market 2011-2015 (US$ billion)
  • Exhibit 14: Global Biopharmaceuticals Market by Geographical Segmentation 2011
  • Exhibit 15: Hepatitis C Infection by Source in 2011
  • Exhibit 16: Global Biopharmaceuticals Market by Vendor Segmentation 2011
Show More
Pricing
Get Notified
Email me when related reports are published